Tisento Therapeutics Receives U.S. FDA Fast Track Designation for Zagociguat for the Treatment of MELAS
Global Phase 2b PRIZM Study of Zagociguat is Currently Enrolling Participants with MELASCAMBRIDGE, Mass., June 17, 2025 (GLOBE NEWSWIRE) --...
Global Phase 2b PRIZM Study of Zagociguat is Currently Enrolling Participants with MELASCAMBRIDGE, Mass., June 17, 2025 (GLOBE NEWSWIRE) --...
Showcasing Global Utility of its QAPs at Point-of-Care Testing ConferenceMISSISSAUGA, Ontario, June 17, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc....
New York, New York--(Newsfile Corp. - June 17, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company")...
Rolling Out Nationwide Starting June 18 at Total Wine & More, DrinkBecketts.com, and Select Independent RetailersToronto, Ontario and Los Angeles,...
Moncton, New Brunswick and Cambridge, Massachusetts--(Newsfile Corp. - June 17, 2025) - Breathe BioMedical, a company developing a breath analytics...
Paris Air Show, Le Bourget – June 16, 2025 – Booth B46 (Alliance NewSpace Pavilion, Paris Space Hub) PARIS, June...
Authored by 17 experts across healthcare, academia and technology, BRIDGE offers an open framework for turning AI ideas into real-world...
TEL AVIV, Israel, June 17, 2025 /PRNewswire/ -- MedHub-AI, pioneer of AI-based FFR "AutocathFFR" software, today announced a distribution agreement with...
MILPITAS, Calif.--(BUSINESS WIRE)--#DiscoverAmazing--Amazfit, a leading global smart wearable brand owned by Zepp Health (NYSE: ZEPP), a health technology company, today...
Accelerating AI-Powered Automation for Healthcare Operations SEATTLE, June 16, 2025 /PRNewswire/ -- AffableBPM is proud to announce its successful graduation...